Medicines co /de (MDCO)
CashFlow / TTM
Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10Jun'10Mar'10
Cash flows from operating activities:
Net loss

-236,388

-218,028

-212,170

-123,156

-258,942

-233,483

-576,554

-708,373

-652,971

-709,067

-129,378

-119,172

-202,386

-221,256

-450,216

-352,746

-152,054

-63,702

-22,337

-32,348

-25,882

-1,347

21,861

15,260

34,755

36,273

31,993

51,170

50,171

113,521

111,207

127,877

166,867

115,458

119,444

104,635

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

2,670

2,751

2,968

3,195

6,277

11,690

14,672

21,974

26,199

28,183

31,729

31,042

33,174

34,494

34,619

34,837

32,538

32,301

34,021

34,398

38,310

36,449

34,447

32,238

21,837

16,399

11,310

7,270

7,118

6,926

6,371

6,231

5,553

5,390

5,369

6,124

0

0

0

Amortization of net premiums and discounts on available for sale securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-209

-430

-658

-767

-734

-513

-797

-1,331

-2,021

-2,849

-3,167

-3,339

-3,260

0

0

0

Amortization of long term debt financing costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,292

1,253

1,216

1,179

1,144

1,112

881

598

0

0

0

-

-

-

-

-

-

-

-

Amortization of Debt Discount (Premium)

35,159

32,624

30,338

27,922

27,069

26,577

26,640

26,868

27,115

27,234

26,855

26,182

25,536

25,010

24,460

23,676

21,563

18,140

14,841

11,920

10,433

10,279

10,128

9,978

9,832

9,702

7,751

5,306

0

0

0

-

-

-

-

-

-

-

-

Unrealized foreign currency transaction losses, net

144

143

119

57

-793

-1,784

-2,596

-2,180

-460

154

16

941

-278

291

595

173

522

451

871

833

868

434

-102

-143

-49

323

235

573

532

-69

391

-562

25

140

149

1,217

0

0

0

Stock compensation expense

19,359

19,190

18,062

18,070

20,686

24,393

29,331

31,520

30,524

30,636

30,690

30,987

31,173

30,873

29,927

30,605

33,548

34,271

34,557

34,311

31,904

28,941

25,839

23,078

19,759

18,146

16,477

14,981

13,773

12,838

11,872

11,017

9,857

8,730

7,854

8,336

0

0

0

Deferred tax benefit

-

-

-

-

-

-

-

-

-

-

-

-23

-11,560

-36,603

-53,726

-53,292

-50,290

-23,345

-7,667

-5,565

-5,550

-8,173

-3,173

-10,272

18,753

23,612

24,946

30,376

23,372

-47,024

-53,458

-53,246

-112,687

-46,538

-43,706

-43,592

0

0

0

Excess tax benefit from share-based compensation arrangements

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-277

-509

1,443

3,413

3,660

5,697

7,675

6,477

7,001

4,834

1,558

10,445

9,632

9,765

9,393

0

0

0

-

-

-

-

Gain on sale of business

0

0

0

168,955

168,955

168,955

168,955

0

0

0

288,301

289,305

289,305

289,305

1,004

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on sale of assets

22,056

29,082

29,082

28,582

0

0

0

-

-

-

-

-

-

-

-

-543

-559

-553

-558

-35

-26

-25

-27

-39

-55

-67

-128

-69

-35

-327

-259

-299

-597

-287

-287

-293

0

0

0

Gain (Loss) on Investments

-

-

-22,181

-

-

-

-30,000

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain on remeasurement of equity investment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

22,597

22,597

22,597

22,741

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Reserve for excess or obsolete inventory

2

4

20

-390

15,264

14,912

17,043

17,453

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in contingent purchase price

0

0

4

-258

-7,257

-14,929

-27,561

-18,787

-1,380

18,529

33,865

23,981

19,428

7,938

17,489

20,278

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss in equity investment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,855

-1,711

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Adjustment to contingent purchase price

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

3,830

8,245

2,388

1,460

5,571

5,848

5,655

4,956

-2,272

-2,271

-2,260

-1,720

0

0

0

Changes in operating assets and liabilities:
Accrued interest receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-150

-347

-413

-225

-23

-26

-29

-595

-534

-905

-472

-355

-222

364

0

0

0

Accounts receivable

1,236

-4,340

-9,165

-4,959

-899

-3,091

-5,374

-9,180

-20,495

-32,878

-20,164

-30,144

-11,428

-4,121

-56,648

-103,100

-79,011

-66,629

-4,061

54,739

15,164

28,703

12,913

15,017

20,074

24,574

23,051

11,120

10,927

-625

18,740

28,086

38,424

45,354

19,332

16,627

0

0

0

Inventory, net

-860

-804

-848

-2,199

-6,737

-11,374

-8,514

-6,511

-400

8,039

14,096

15,653

25,612

24,893

25,659

69,318

64,207

50,103

41,499

-5,627

-17,019

-1,438

1,016

10,130

29,061

39,549

34,378

31,152

32,010

18,310

17,573

19,794

616

239

7,170

-701

0

0

0

Prepaid expenses and other assets

-6,202

-4,007

-5,838

-9,663

-197

-2,626

-2,179

-534

-4,548

-7,860

-3,841

-569

-3,999

6,706

5,865

5,286

7,785

4,424

2,031

3,559

908

-367

-8,716

-39

-645

-1,727

6,888

-1,516

5,495

3,825

-2,913

6,763

21

2,511

6,755

-5,031

0

0

0

Accounts payable

-136

-1,240

5,935

-9,514

-3,005

-9,770

-10,601

-17,222

-7,031

-10,148

2,189

-7,398

1,210

9,207

1,945

16,362

9,473

10,417

6,567

-6,866

-25,741

-582

-5,746

-1,319

24,911

-2,062

-6,902

18,903

-4,046

-9,952

4,111

-2,203

-2,305

9,121

5,995

165

0

0

0

Accrued expenses

-2,686

-22,647

-54,772

-50,390

-22,003

-3,257

42,990

31,526

6,632

2,674

-27,447

-37,233

-66,956

-41,592

-26,452

-39,501

5,930

-40,538

-27,912

24,058

256

52,834

41,149

31,192

204

6,514

-2,498

-40,160

26,389

22,578

29,124

71,608

44,009

12,986

11,348

-736

0

0

0

Other current liabilities

-79

-256

-390

-4,437

-6,367

-12,978

-17,510

-13,757

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments on contingent purchase price

0

2

40

59

103

40,163

40,219

52,543

53,544

13,482

13,388

1,045

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-22,536

7,335

11,312

8,386

32,816

5,554

8,411

5,257

-138

1,187

891

3,854

2,115

255

549

1,685

671

1,697

58

125

693

-210

-213

-616

0

0

0

Other liabilities

-7,199

-5,854

-2,902

4,272

-165

-851

1,758

-7,659

-8,482

-12,403

-15,797

-11,446

582

4,838

5,458

549

486

2,393

264

3,394

-2,124

-3,715

-1,333

1,335

-221

-221

-223

-265

180

174

171

171

68

70

71

62

0

0

0

Net cash used in operating activities

-198,336

-195,052

-202,297

-261,795

-286,282

-358,277

-358,007

-368,288

-367,098

-286,332

-324,531

-323,309

-373,489

-328,288

-275,316

-197,965

-65,391

-59,235

31,374

67,314

89,078

143,546

134,296

91,420

75,239

32,715

13,428

46,346

56,459

66,133

62,369

96,375

79,451

63,135

79,156

67,467

0

0

0

Cash flows from investing activities:
Proceeds from sale of fixed assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

250

250

250

250

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of available for sale securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

65,354

65,102

65,102

36,970

33,583

61,245

96,220

130,793

128,240

0

0

0

Proceeds from sale of assets

3,272

13,172

13,172

12,672

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from maturities and sales of available for sale securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

50,656

64,501

56,401

43,901

38,881

49,393

87,138

108,399

126,713

130,856

122,151

124,104

108,640

0

0

0

Purchases of fixed assets

0

0

0

7

7

84

3,199

4,525

0

0

0

-

-

-

1,923

2,555

3,630

3,346

4,528

7,289

11,966

15,846

16,115

13,574

7,998

3,676

1,857

1,005

1,085

1,398

964

1,269

1,068

580

622

340

0

0

0

Payments for intangible assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

112,617

112,617

112,617

105,617

15,000

0

0

0

-

-

-

-

36,678

43,678

43,678

43,678

7,000

0

0

0

-

-

-

-

Other investments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,125

2,875

3,375

3,375

2,500

0

0

0

-

-

-

-

-

-

-

-

Acquisition of business, net of cash acquired

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

28,397

28,397

28,460

87,268

58,934

198,934

299,750

240,943

542,579

402,579

301,700

301,699

0

0

0

0

-

-

-

-

-

-

-

-

Proceeds from Divestiture of Businesses

0

0

0

166,383

166,383

166,383

166,383

0

0

0

263,807

437,875

437,875

437,875

174,068

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Adjustment to goodwill

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

263

0

0

0

Change in restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

3,686

-10

-5

-35

-68

-30

-26

-92

-94

-79

-89

-11

-2

-1,147

-1,117

-3,148

-3,054

-3,063

-3,092

-1,049

-1,136

-1,272

-1,278

-1,278

0

0

0

Net cash provided by investing activities

3,272

13,172

13,172

179,048

218,467

297,834

163,159

-4,550

-44,337

-138,343

250,311

425,699

423,135

411,989

169,923

-123,511

-124,553

-127,370

-200,762

-84,756

-227,431

-296,042

-231,369

-504,361

-348,949

-261,203

-290,045

-63,508

-65,418

-27,477

22,379

78,410

69,679

26,623

-6,033

-18,399

0

0

0

Cash flows from financing activities:
Proceeds from issuances of common stock, net

11,587

9,806

7,597

15,608

23,508

24,675

32,610

48,621

47,080

52,724

53,366

33,776

32,884

91,324

88,327

95,198

93,379

28,622

20,736

17,343

28,725

34,157

53,059

74,212

60,498

62,423

48,790

22,935

24,359

13,878

8,416

6,725

4,569

3,771

4,716

3,361

0

0

0

Payments on contingent purchase price

0

0

340

511

915

1,469

1,971

10,523

11,602

12,447

15,354

9,404

35,464

37,340

159,374

157,601

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Milestone payments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from the issuance of convertible senior notes

172,500

172,500

172,500

163,000

0

0

0

-

-

-

-

-

-

-

-

400,000

400,000

400,000

400,000

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Debt issuance costs

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

12,769

12,769

12,769

12,769

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of shares of non-controlling interest

-

-

-

-

-

-

-

167

167

167

167

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Excess tax benefit from share-based compensation arrangements

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-277

-509

1,443

3,413

3,660

5,697

7,675

6,477

7,001

4,834

1,558

10,445

9,632

9,765

9,393

0

0

0

-

-

-

-

Net cash provided by financing activities

339,926

338,145

174,013

172,633

22,591

23,201

-24,363

-17,071

-19,689

-14,887

84,049

70,576

43,624

100,241

-70,765

324,828

340,333

278,840

396,505

8,833

32,138

227,417

248,356

271,487

256,575

69,424

250,052

220,921

231,232

219,938

18,181

16,118

4,569

3,771

4,716

3,361

0

0

0

Effect of exchange rate changes on cash

1,336

1,576

52

-1,766

-2,440

-2,250

-1,036

-58

1,122

1,393

299

-700

-1,722

-2,489

-719

-920

2,180

2,238

1,580

2,623

94

458

-1,298

-1,265

-894

-385

-571

305

81

-1,862

-176

-1,885

-833

383

145

1,710

0

0

0

Increase (decrease) in cash, cash equivalents and restricted cash

146,198

157,841

-15,060

88,120

-47,664

-39,492

-220,247

-389,967

-430,002

-438,169

10,128

172,266

91,548

181,453

-176,877

2,432

152,569

94,473

228,697

-5,986

-106,121

75,379

149,985

-142,719

-18,029

-159,449

-27,136

204,064

222,354

256,732

102,753

189,018

152,866

93,912

77,984

54,139

0

0

0

Supplemental disclosure of cash flow information:
Interest paid

24,540

21,069

21,069

21,069

21,069

21,107

21,484

22,561

22,939

17,366

18,880

12,269

13,782

13,837

13,837

8,837

0

0

0

-

-

-

-

4,374

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Taxes paid

-

-

-

-

-

-

-

-

-

-

-

-

-

80

93

114

142

232

236

1,371

7,955

9,237

8,917

9,137

3,054

1,790

3,095

1,709

1,222

1,106

6,264

6,850

8,253

8,262

2,184

1,699

0

0

0